LRRC32/GARP Antibody (855151) [Janelia Fluor® 525]
Novus Biologicals, part of Bio-Techne | Catalog # FAB6055JF525
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry
Label
Janelia Fluor 525
Antibody Source
Monoclonal Rat IgG2A Clone # 855151
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
recombinant human LRRC32/GARP
Accession # Q14392
Accession # Q14392
Specificity
Detects human LRRC32/GARP in ELISAs. In direct ELISAs, no cross-reactivity with recombinant
mouse LRRC32 is observed.
Clonality
Monoclonal
Host
Rat
Isotype
IgG2A
Applications for LRRC32/GARP Antibody (855151) [Janelia Fluor® 525]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
0
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: LRRC32/GARP
Long Name
Leucine-rich Repeat Containing 32/Glycoprotein A Repetitions Predominant
Alternate Names
D11S833E, GARP, Garpin
Gene Symbol
LRRC32
Additional LRRC32/GARP Products
Product Documents for LRRC32/GARP Antibody (855151) [Janelia Fluor® 525]
Product Specific Notices for LRRC32/GARP Antibody (855151) [Janelia Fluor® 525]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...